Infection Control Industry Overview
The global infection control market size was estimated at USD 201.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. The market is predominantly driven by growing number of surgical procedures that require high-intensity infection prevention. The high preference is presumed to be a consequence of positive clinical outcomes associated with usage of infection control. The covid-19 pandemic has positively impacted market growth as the demand for sterilization and disinfection in hospitals and clinics, pharmaceutical, and medical device companies has increased.
For instance, the manufacturing of sanitizer products witnessed rise of 60% during the pandemic in the U.S. alone. This shows the growth potential for infection control products in the coming years. An increase in outsourcing of sterilization services and the introduction of advanced sterilizing solutions are further contributing towards the growth of the market for infection control. The rising number of government initiatives to ensure a high degree infection prevention is presumed to be a significant growth driver.
Gather more insights about the market drivers, restraints, and growth of the Global Infection Control market
Government organizations are increasingly involved in issuing guidelines in order to promote awareness pertaining to efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for the prevention and control of pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene, usage of personal protective equipment, to guidelines for disinfection, and sterilization.
According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs. The aforementioned statistics exemplify the high need for stringent prevention and control. Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, MRSA constitute majority of the overall hospital-acquired infections. Other major Hospital-acquired Infections (HAI) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstreams. HAI is believed to be one of the major concerns, that affects patient recovery, thereby, creating a major impact on mortality rates globally.
According to a practical guide published by the WHO on the prevention of HAI, the increase in hospitalization duration with surgical infections was found to be approximately 8 days. These prolonged stays are predicted to be a significant contributor to the overall costs, incurred during the hospitalization period, thus, raising the clinical urgency for adoption of infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers as a consequence of excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, laboratory equipment, creating a resource allocation imbalance.
Browse through Grand View Research's Medical Devices Industry Research Reports.
High Level Disinfection Services Market - The global high level disinfection services market size was valued at USD 22.39 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.30% from 2022 to 2030.
Wound Care Market - The global wound care market size was valued at USD 21.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.15% from 2023 to 2030.
Infection Control Market Segmentation
Grand View Research has segmented the global infection control market on the basis of type, end use, and region:
Infection Control Type Outlook (Revenue, USD Billion, 2017 - 2030)
- Equipment
- Services
- Consumables
Infection Control End-use Outlook (Revenue, USD Billion, 2017 - 2030)
- Hospitals
- Medical Device Companies
- Clinical Laboratories
- Pharmaceutical Laboratories
- Others
Infection Control Regional Outlook (Revenue, USD Billion, 2017 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Share Insights
March 2017: 3M and Kimberly-Clark Health Care signed an alliance to co-develop and deliver surgical and infection prevention solutions utilizing their respective expertise.
Key Companies profiled:
Some of the prominent players in the infection control market include:
- 3M Company
- Belimed AG
- Halyard Health, Inc.
- Getinge Group
- Advanced Sterilization Products
- Matchana Group
- Sterigenics International
- MMM Group
- Cantel Medical Corporation
- STERIS Corporation
Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment